[1]
S. Srikumar, A. Muthiah, and S. Perumal, “Role of tocilizumab therapy in COVID-19 patients: a systematic review”, Int J Basic Clin Pharmacol, vol. 11, no. 4, pp. 323–330, Jul. 2022.